Immunai
Mirko Andreoli is a Senior Scientist at Immunai, specializing in molecular profiling and single-cell technology since March 2022. Prior to this role, Mirko served as a Research Associate at Weill Cornell Medicine, managing a bio-archive of clinical samples and conducting research on pulmonary studies from December 2017 to March 2022. Earlier experience includes a position as a Senior Research Technician at Cold Spring Harbor Laboratory, focusing on cancer biology and metastatic processes, and as an Associated Researcher at Danbury Hospital, where research involved molecular biology techniques in cancer studies. Additional roles include serving as a Chemical Analyst at Zhermack Spa, analyzing materials for quality control, and as a Research Fellow at the University of Padua, developing molecular assays in food safety. Mirko holds a Ph.D. in Biochemistry and Molecular Biology with a focus on molecular pathology in oncologic gynecology from Università degli Studi di Padova, along with a Master's degree in Biotechnology for Safety and Food Hygiene and a Bachelor's degree in Biotechnology.
Immunai
2 followers
Immunai is comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes.